Source: DGNews | Posted 9 years ago
FDA Approves Avapro (Irbesartan) For The Treatment Of Diabetic Nephropathy (Kidney Disease) In Patients With High Blood Pressure And Type 2 Diabetes
Tags:
PRINCETON, N.J., and PARIS, FRANCE -- September 18, 2002 -- Bristol-Myers Squibb Company (NYSE: BMY) and Sanofi-Synthelabo (Euronext: SAN; NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Avapro
Comments